(UroToday.com) The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was host to a kidney and bladder cancers poster session. Dr. David Cade presented LUTEON, an ongoing phase III trial ...
Finally, current quality-of-life tools do not fully capture the patient experience. Emerging approaches incorporating patient ...
Figure][1] Toni K. Choueiri, MD Toni K. Choueiri, MD, is the director of the Lank Center for Genitourinary Oncology at ...
AstraZeneca announces CARES phase III clinical programme fails to meet primary endpoint in overall light chain amyloidosis population: Cambridge, UK Monday, June 1, 2026, 12:00 Hr ...
CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key ...
Study explored safety and efficacy of novel PRRT approach using SSTR antagonist DOTA-LM3 labeled to the alpha-emitting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results